Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis

Published:2011 Issue:9 Volume:50 Page:1009-1013
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Durakovic Nadira¹,Radojcic Vedran¹,Boban Ana¹,Mrsic Mirando¹,Sertic Dubravka¹,Serventi-Seiwerth Ranka¹,Nemet Damir¹,Labar Boris¹

Affiliation:

1. Department of Internal Medicine, Division of Hematology, Clinical Hospital Center Zagreb, Croatia

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/50/9/50_9_1009/_pdf

Reference10 articles.

1. Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

2. Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines

3. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria

4. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients;Cancers;2024-05-19

2. Efficacy of Colistin Therapy in Patients with Hematological Malignancies: What if There is Colistin Resistance?;European Journal of Therapeutics;2023-03-30

3. Localized pmrB hypermutation drives the evolution of colistin heteroresistance;Cell Reports;2022-06

4. Localized hypermutation drives the evolution of unstable colistin resistance in Pseudomonas aeruginosa;2021-08-10

5. Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins;Clinical Microbiology and Infection;2021-05